View More View Less
  • 1 University Hospital Rostock, Schillingallee 70, 18057 Rostock, Germany

Background

Chemiluminescent or enzyme-linked fluorescent immunoassays are commonly used to diagnose Clostridium difficile-associated diarrhea.

Methods

The LIAISON analyzer (DiaSorin, Italy) was compared to miniVIDAS (bioMérieux, France) and, furthermore, to culture of toxigenic strains. In total, 249 native stool samples were analyzed. Sensitivities, specificities, and positive and negative predictive values were investigated. Furthermore, performance under routine conditions was assessed.

Results

The glutamate dehydrogenase chemiluminescent immunoassay (GDH-CLIA) assay revealed a high sensitivity and negative predictive value. The toxins A&B assays exhibited approximately the same low sensitivity and high specificity. Technical drawbacks experienced with the LIAISON analyzer in 48% of the analyses considerably delayed the time to the first diagnostic report and interfered with laboratory routine workflow.

Conclusion

The analytical performance of the investigated platforms should be reflected in the context of implementation into the laboratory workflow.

If the inline PDF is not rendering correctly, you can download the PDF file here.

  • 1.

    Burnham CA , Carroll KC: Diagnosis of Clostridium difficile infection: an ongoing conundrum for clinicians and for clinical laboratories. Clin Microbiol Rev 6, 604630 (2013)

    • Search Google Scholar
    • Export Citation
  • 2.

    Cohen SH , Gerding DN, Johnson S, Kelly CP, Loo VG, McDonald LC, Pepin J, Wilcox MH: Society for Healthcare Epidemiology of America; Infectious Diseases Society of America. Clinical practice guidelines for Clostridium difficile infection in adults: 2010 update by the society for healthcare epidemiology of America, (SHEA) and the infectious diseases society of America, (IDSA). Infect Control Hosp Epidemiol 31, 431455 (2010)

    • Search Google Scholar
    • Export Citation
  • 3.

    Crobach MJT , Dekkers OM, Wilcox MH, Kuijper EJ: European Society of Clinical Microbiology and Infectious Diseases (ESCMID): data review and recommendations for diagnosing Clostridium difficile-infection (CDI). Clin Microbiol Infec 15, 10531066 (2009)

    • Search Google Scholar
    • Export Citation
  • 4.

    Shin BM , Kuak EY, Lee EJ, Songer JG: Algorithm combining toxin immunoassay and stool culture for diagnosis of Clostridium difficile infection. J Clin Microbiol 47, 29522956 (2009)

    • Search Google Scholar
    • Export Citation
  • 5.

    Fruttero ER , Picciolo G, De Matteis JA: Operative performances and efficiency for infectious disease testing of two immunochemistry analyzers – Abbott ARCHITECT i2000SR and DiaSorin Liaison XL. Clin Chem Lab Med 53, e1923 (2015)

    • Search Google Scholar
    • Export Citation
  • 6.

    Oggioni M , Bielli A, Nava A, Campisi DAP: Evaluation of LIAISON® C. difficile GDH and LIAISON® C. difficile Toxin, A&B in Copan FecalSwab™ samples in a three-step algorithm for the diagnosis of Clostridium difficile infection. Microbiologia Medica 30, 49534954 (2015)

    • Search Google Scholar
    • Export Citation
  • 7.

    Krutová MJ Matejková M , Hubácek P, Nyc O: Diagnosis of Clostridium difficile infections: comparative study of two immuno enzyme assays with confirmation by PCR and culture followed by PCR ribotyping. Epidemiol Mikrobiol Imunol 63, 99102 (2014) [Czech]

    • Search Google Scholar
    • Export Citation
  • 8.

    Eastwood K , Else P, Charlett A, Wilcox M: Comparison of nine commercially available Clostridium difficile toxin detection assays, a real-time PCR assay for C. difficile tcdB, and a glutamate dehydrogenase detection assay to cytotoxin testing and cytotoxigenic culture methods. J Clin Microbiol 47, 32113217 (2009)

    • Search Google Scholar
    • Export Citation

Monthly Content Usage

Abstract Views Full Text Views PDF Downloads
Oct 2020 0 0 0
Nov 2020 0 3 2
Dec 2020 0 2 3
Jan 2021 0 1 0
Feb 2021 0 0 0
Mar 2021 0 0 2
Apr 2021 0 0 1